A quick 2-step check to see if you qualify for a free TSH (thyroid) test at this clinic. Takes about 2 minutes.
A and B: Merck's current algorithm in two wording styles. C: Spectrum's proposed flow (fast-track priority risk factors). Ticks carry over when you switch.
We use this to check two risk factors automatically, so you do not have to work them out yourself.
For patients taking the TSH test today.
Items 1 and 2 are the big ones. Tap the "C · Proposed" tab to demo item 1 live during the meeting. Nothing here blocks the design work except item 4 (TSH cutoffs). Already resolved with Merck: the symptom threshold is 3 or more of the other symptoms, and that logic is built into all three checkers. Note: the Step 2 symptom list comes from the MEMS / Merck "Transform Your Life" checker and is kept fully intact in every version, including C. Our proposals only change who must take the symptom check, not the check itself.
In the current flow, a pregnant woman or a patient with suspected Graves' disease must still report 3 or more symptoms to qualify. But subclinical hypothyroidism often has few or no symptoms, so the patients Step 1 flags as highest-risk are the most likely to be screened out at Step 2. Most clinical guidance supports testing these groups on the risk factor alone.
The form should recruit patients, not overrule the doctor. A GP who suspects thyroid disease should be able to test a patient regardless of the form outcome.
Almost no patient knows their pulse is slow, so the "both key symptoms" pathway (slow heart rate + feeling cold) will almost never trigger on a self-filled form. In practice that leaves only the 3-symptom route.
We need the device's reference ranges to build the result bands in the dashboard (the TSH equivalent of our HbA1c bands) and to define which results get flagged for referral.
Already-diagnosed, already-treated patients defeat the purpose of screening, but they may still walk in wanting the free test.
Biotin (common in hair / skin / nail supplements) can distort immunoassay-based rapid tests. If the Wondfo cartridge is biotin-sensitive, patients need a 48-hour pause before testing.
Merck's flow stops at screening. The patient's result screen and the nurse's script both need to say what happens next.
The Transform Your Life campaign (MEMS + Merck) lists its at-risk groups as: all adult women, especially expectant mothers and those having difficulty conceiving; people over 50; Type 1 diabetes or other autoimmune disease; and family history of thyroid conditions. The deck's Step 1 uses age over 60 (not 50) and leaves out family history entirely. Merck's own campaign casts a wider net than this screening flow does.